Carlyle Group (CG) is back in focus after reporting a weak first quarter, with revenue of US$254 million and a net loss of US$132.2 million, sharply different from last year’s profit.

The weak first quarter and recent shelf registration filing have weighed on sentiment, with the stock’s 1 day share price return down 4.01% and its year to date share price return down 21.07%, even as the 3 year total shareholder return is 91.82%.

If this earnings miss has you rethinking your opportunities in asset managers and credit, it could be a good moment to scan 19 top founder-led companies

With Carlyle stock down 21.07% year to date, but trading at a 26% discount to the average analyst price target and a reported 63.58% intrinsic discount, is this selloff creating a buying opportunity or is the market already pricing in future growth?

Most Popular Narrative: 22.3% Undervalued

Against Carlyle Group's last close of $48.04, the most followed narrative points to a fair value of $61.81, using a 9.48% discount rate to bridge today’s price and long term cash flow expectations.

Expanding global wealth and broader retail investor participation, including new evergreen products (e.g., CAPM, CPEP) and partnerships (e.g., UBS), are driving robust and recurring fundraising, positioning Carlyle to further broaden its AUM base and capture a greater share of the growing demand for private market solutions, which is likely to boost fee revenues and long-term earnings growth.

Want to see what this fundraising engine is assuming on revenue, margins and earnings several years out? The fair value hinges on a tight set of growth, profitability and valuation multiples that are all spelled out in the narrative, including how they line up with the current analyst price target and discount rate.

Result: Fair Value of $61.81 (UNDERVALUED)

However, this hinges on continued fundraising momentum and fee strength, and tighter regulation or tougher competition in alternatives could quickly challenge those assumptions and compress returns.

Another View: What The P/E Is Telling You

The SWS fair ratio suggests Carlyle Group's P/E of 31.6x is high compared with a fair ratio of 17.1x, even if it sits below the US Capital Markets industry at 41.2x and a peer average of 45.7x. If earnings do not catch up, that gap could matter more than any DCF output.

To see how this pricing gap lines up with the earnings profile and peer set, take a closer look at the detailed valuation breakdown, including the fair ratio and P/E context, in the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of caution and opportunity leaves you on the fence, act while the data is fresh. Weigh both sides with the 3 key rewards and 4 important warning signs

Looking for more investment ideas?

If Carlyle has sharpened your focus, do not stop here. Broaden your watchlist now so you are not looking back wishing you had acted sooner.

• Spot potential high flyers early by scanning 24 elite penny stocks with strong financials before they become widely followed and harder to access at lower valuations.
• Zero in on quality at a discount by using the 49 high quality undervalued stocks and quickly see which stocks align with your risk and return expectations.
• Strengthen your core holdings with companies that prioritise resilience through the solid balance sheet and fundamentals stocks screener (45 results) and aim for a portfolio built on sturdier financial foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.